Market revenue in 2023 | USD 30.1 million |
Market revenue in 2030 | USD 35.9 million |
Growth rate | 2.6% (CAGR from 2023 to 2030) |
Largest segment | Cardiopulmonary perfusion system |
Fastest growing segment | Cardiopulmonary Perfusion System |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cardiopulmonary Perfusion System, Cell Perfusion System, Ex-Vivo Organ Perfusion System |
Key market players worldwide | Getinge AB ADR, Medtronic PLC, LivaNova PLC, Terumo Corp, Nipro Corp, Fresenius Medical Care AG, Repligen Corp, Spectrum Brands Holdings Inc, Merck KGaA, Xvivo Perfusion AB |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to perfusion systems market will help companies and investors design strategic landscapes.
Cardiopulmonary perfusion system was the largest segment with a revenue share of 43.19% in 2023. Horizon Databook has segmented the Spain perfusion systems market based on cardiopulmonary perfusion system, cell perfusion system, ex-vivo organ perfusion system covering the revenue growth of each sub-segment from 2018 to 2030.
Spain has the highest life expectancy in the EU, averaging 82 years, resulting in a patient population with a higher prevalence of chronic ailments and health challenges associated with old age. Data from the Spanish National Statistics Institute reveals that as of June 2022, over 20% of Spain’s population, totaling 47 million, is aged over 65 years.
In Spain, several people are dealing with long-term health problems that need surgeries, and doctors are using newer & better ways to perform these surgeries. According to the Institut d’Investigació Biomèdica de Bellvitge report of December 2022, nearly 90% of the health issues and deaths in Spain are due to noninfectious diseases, such as heart disease, stroke, COPD, and ARDS.
Moreover, leading companies, such as Terumo Corporation, Medtronic Ibérica S.A.U. (Almacén), and Getinge, play a significant role in this field. Hence, with the growing need for better techniques to treat heart failure, these companies are working on introducing new & improved products and methods for surgeries in Spain.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain perfusion systems market , including forecasts for subscribers. This country databook contains high-level insights into Spain perfusion systems market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account